课题基金 / 基金详情

MEDICAL THERAPY IN BENIGN PROSTATIC HYPERPLASIA

MEDICAL THERAPY IN BENIGN PROSTATIC HYPERPLASIA
良性前列腺增生的药物治疗
批准号:
2150920
负责人:
JOE WESLEY RAMSDELL
金额:
$25.04万
依托单位国家:
美国
项目类别:
财政年份:
1995
资助国家:
美国
项目状态:
已结题
起止时间:
1995-04-27 至 2002-03-31

项目摘要

项目成果

JOE WESLEY RAMSDELL的其他基金

相关文献

中文摘要
翻译
这项申请的资金将建立一个临床中心 《良性前列腺增生症药物治疗的临床试验》,a 由美国国家糖尿病研究所主办的多中心试验 消化和肾脏疾病在大学临床试验中心 加州大学圣地亚哥分校(UCSD)。试验的主要目的是 以确定药物治疗(非那雄胺和/或多沙唑嗪)是否延迟或 防止良性前列腺增生症的发展。如果被选为临床中心, UCSD临床试验中心将招募、筛选并进入评估 在两年的注册期内将240名合适的受试者纳入研究, 并按照标准化的多中心方案完成研究。
英文摘要
Funding of this application will establish a Clinical Center for the "Clinical Trial of Medical Therapy in Benign Prostatic Hyperplasia", a multi-center trial sponsored by the national Institute of Diabetes and Digestive and Kidney Diseases at the Clinical Trials Center, University of California, San Diego (UCSD). The primary objective of the trial is to ascertain if medical therapy (finasteride and/or doxazosin) delays or prevents the progression of BPH. If selected as a clinical center, the UCSD Clinical Trials Center will recruit, screen and enter for evaluation 240 suitable subjects into the study over a two year enrollment period, and complete the study following the standardized multi-center protocol.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Smoking in Asthmatics Pilot Study
Smoking in Asthmatics Pilot Study
COPD EPIDEMIOLOGY WHOLE GENOME ANALYSIS PROJECT
CORE--EDUCATION AND TRAINING